<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Drug resistance in haemopoietic cells may be partly related to the expression of the <z:chebi fb="0" ids="16856">glutathione</z:chebi>-s-transferase (GST) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> and mdr-1 genes </plain></SENT>
<SENT sid="1" pm="."><plain>We have used <z:chebi fb="40" ids="33697">RNA</z:chebi> slot blotting techniques to investigate the expression of GST <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> in peripheral blood and bone marrow of eleven <z:mpath ids='MPATH_458'>normal</z:mpath> subjects, nine patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), eighteen patients with <z:hpo ids='HP_0011009'>acute</z:hpo> myeloblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), and thirty-two patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocyte <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (CLL) </plain></SENT>
<SENT sid="2" pm="."><plain>We found increased expression of GST <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> in 8 of 9 MDS, (7 peripheral blood, 1 bone marrow) 12 of 18 AML (5 peripheral blood, 7 bone marrow; 4 of 5 untreated, 1 of 5 secondary, 7 of 11 relapse or refractory) and in the peripheral blood of 24 of 32 CLL (3 of 7 untreated, 21 of 25 treated) relative to <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="3" pm="."><plain>Increased expression of GST <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> can occur at any stage of disease and shows no clear relation to mdr-1 expression except, possibly, in CLL </plain></SENT>
<SENT sid="4" pm="."><plain>In 3 AML patients GST <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> transcript levels were the same or lower on relapse compared to presentation </plain></SENT>
<SENT sid="5" pm="."><plain>Upregulation of the GST <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> gene could not be demonstrated in 2 CLL patients in response to treatment with intermittent <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> </plain></SENT>
</text></document>